Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult Subjects
Clinical trial NCT00978614 · COMPLETED
Trial details
- NCT number
- NCT00978614
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2010-04-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.